calendar
5,056 catalysts · 4,779 phase readout · 2,339 8k filing · 285 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion
next 91 dayslessmore
MonWedFri
5,056 catalysts · 4,779 phase readout · 2,339 8k filing · 285 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion
Sponsor: University of Faisalabad. Phase: NA. Conditions: Myopia, Progressive Myopia, Refractive Errors
Sponsor: AstraZeneca. Phase: PHASE1. Conditions: ER+ HER2- Advanced Breast Cancer, High-grade Serous Ovarian Cancer (HGSOC)
Sponsor: Centre Hospitalier Universitaire Dijon. Phase: NA. Conditions: Vestibular Stimulation
Sponsor: The First Affiliated Hospital of Bengbu Medical University. Phase: NA. Conditions: Coronary Disease
Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Epilepsy
Sponsor: Jacqueline Garcia, MD. Phase: PHASE1. Conditions: Acute Myeloid Leukaemia (AML), Leukemia, Blood Cancer, Blood Cancers
Sponsor: The National Center on Addiction and Substance Abuse at Columbia University. Phase: NA. Conditions: Internalizing Disorders, Substance Use Disorders
Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE1. Conditions: Relapsed/Refractory Acute Myeloid Leukemia(AML)
Sponsor: Gilgamesh Pharmaceuticals. Phase: PHASE2. Conditions: Major Depressive Disorder
Sponsor: Gan & Lee Pharmaceuticals.. Phase: PHASE1. Conditions: Prostate Cancer
Sponsor: Poznan University of Medical Sciences. Phase: NA. Conditions: Osteoarthritis Shoulder
Sponsor: University Hospital, Bordeaux. Phase: NA. Conditions: Cystic Fibrosis
Sponsor: Fundación Universitaria del Area Andina. Phase: NA. Conditions: Kidney Transplant Recipients, Metabolic Syndrome, Cardiovascular Risk Factors
Sponsor: Second Xiangya Hospital of Central South University. Phase: PHASE2. Conditions: Non Small Cell Lung Cancer, Immune Checkpoint Inhibitors (ICIs)
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE3. Conditions: Renal Cell Carcinoma
Sponsor: Novartis Pharmaceuticals. Phase: PHASE1. Conditions: Small Cell Lung Carcinoma, Large Cell Neuroendocrine Carcinoma of the Lung, Neuroendocrine Prostate Cancer, Gastroenteropancreatic Neuroendocrine Carcinoma
Sponsor: University of Texas Southwestern Medical Center. Phase: PHASE2. Conditions: Breast Cancer Female
Sponsor: University of Minnesota. Phase: PHASE1. Conditions: Epilepsy
Sponsor: University of Michigan. Phase: NA. Conditions: Sleep, Pregnancy Complications
Sponsor: Yonsei University. Phase: . Conditions: Drug Hypersensitivity
Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology. Phase: PHASE1. Conditions: Liver Cirrhosis
Sponsor: Hoffmann-La Roche. Phase: PHASE2. Conditions: Renal Cell Carcinoma
Sponsor: UMC Utrecht. Phase: NA. Conditions: Gastric Cancer
Sponsor: Kafkas University. Phase: NA. Conditions: Hypertension, Mobile Application, Blood Pressure Control, Treatment Adherence, Self-Efficacy
Sponsor: The National Brain Mapping Laboratory (NBML). Phase: NA. Conditions: Multiple Sclerosis
Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Renal Impairment, End-stage Kidney Disease, Healthy Participants
Sponsor: Georgia Tsaousi. Phase: PHASE4. Conditions: Brain Tumor, Metabolic Disturbance, Inflammatory Response, Oxygen Deficiency
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Phase: . Conditions: Migraine
Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE1. Conditions: Primary Central Nervous System Lymphoma (PCNSL), Secondary Central Nervous System Lymphoma (SCNSL)
Sponsor: Antalya City Hospital. Phase: NA. Conditions: Breast Cancer, Lymph Node Dissection, Postoperative Pain, Mastectomy
Sponsor: Nanfang Hospital, Southern Medical University. Phase: NA. Conditions: Pathology Foundation Model
Sponsor: Hoffmann-La Roche. Phase: . Conditions: Locally Advanced Breast Cancer, Metastatic Breast Cancer
Sponsor: University Health Network, Toronto. Phase: PHASE2. Conditions: Prostate Cancer, Prostatectomy
Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Colon Adenocarcinoma, Colorectal Carcinoma, Rectal Adenocarcinoma
Sponsor: Instituto de Investigación Biomédica de Salamanca. Phase: PHASE3. Conditions: Small Cell Lung Carcinoma
Sponsor: National Institute on Drug Abuse (NIDA). Phase: EARLY_PHASE1. Conditions: Normal Physiology
Sponsor: Nikolaj Frost MD. Phase: PHASE4. Conditions: Non-Small Cell Lung Cancer Metastatic
Sponsor: KK Women's and Children's Hospital. Phase: . Conditions: Pediatrics, Intensive Care Unit, Critical Illness
Sponsor: Jiangxi Qingfeng Pharmaceutical Co. Ltd.. Phase: PHASE3. Conditions: Epilepsy, Focal
Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Consciousness Disorders, Disorders of Consciousness Due to Severe Brain Injury
Sponsor: Kathmandu University School of Medical Sciences. Phase: NA. Conditions: Blood Loss, Postoperative, Blood Loss, Surgical, Femoral Fracture, Tibial Fracture
Sponsor: Beijing Tiantan Hospital. Phase: NA. Conditions: Herpes Zoster, Pain
Sponsor: Catholic University of the Sacred Heart. Phase: NA. Conditions: Obesity (BMI > 35)
Sponsor: Central Hospital, Nancy, France. Phase: . Conditions: Antisynthetase Syndrome
Sponsor: Bayer. Phase: PHASE2. Conditions: High-Risk Localized Prostate Cancer
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Activated PI3K Delta Syndrome
Sponsor: University of Stirling. Phase: NA. Conditions: Health Behavior
Sponsor: Ohio State University. Phase: NA. Conditions: Suicide Prevention
Sponsor: Charite University, Berlin, Germany. Phase: NA. Conditions: Psychosis, Psychotic Disorders, Primary Psychotic Disorders, Schizophrenia Spectrum Disorders, Schizophrenia, Schizoaffective Disorder
Sponsor: Boston Children's Hospital. Phase: . Conditions: Intestinal Failure, Hypoglycemia, Hyperglycemia